This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (42)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Still a Well-Kept Secret in the United States

Charles H. Hennekens, MD; Michael A. Jonas; Julie E. Buring, ScD

Arch Intern Med. 1994;154(1):37-40.

Abstract
Acute myocardial infarction (MI) remains far and away the leading cause of death in the United States, and is responsible for approximately 500 000 annual fatalities. However, mortality due to MI has declined substantially in recent decades, owing to advances in treatment as well as prevention. Low-dose aspirin as well as thrombolytic therapy given during acute evolving MI each decrease mortality by about one quarter. Both therapies remain underutilized in the United States. Aspirin can be given to virtually all patients, has a far more favorable safety profile than thrombolysis, and confers a comparable benefit at a small fraction of the cost of thrombolytic agents. The more widespread use of aspirin in acute MI is one of the most important and timely clinical challenges in the United States.

(Arch Intern Med. 1994;154:37-39)

Author Affiliations
From the Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Differences in the views of orthopaedic surgeons and referring practitioners on the determinants of outcome after total hip replacement
Sturmer et al.
J Bone Joint Surg Br 2005;87-B:1416-1419.
ABSTRACT | FULL TEXT  

Evaluation of a Public Education Program Delivered by Firefighters on Early Recognition of a Heart Attack
Meischke et al.
Eval Health Prof 2004;27:3-21.
ABSTRACT  

Resolution of Inflammation: A New Paradigm for the Pathogenesis of Periodontal Diseases
Van Dyke and Serhan
JDR 2003;82:82-90.
ABSTRACT | FULL TEXT  

Electronic Trial Banks: A Complementary Method for Reporting Randomized Trials
Sim et al.
Med Decis Making 2000;20:440-450.
ABSTRACT  

Influencing Care in Acute Myocardial Infarction: A Randomized Trial Comparing 2 Types of Intervention
Sauaia et al.
American Journal of Medical Quality 2000;15:197-206.
ABSTRACT  

The `Heart Attack Survival Kit' project: an intervention designed to increase seniors' intentions to respond appropriately to symptoms of acute myocardial infarction
Meischke et al.
Health Educ Res 2000;15:317-326.
ABSTRACT | FULL TEXT  

Aspirin Use Is Low Among United States Outpatients With Coronary Artery Disease
Stafford
Circulation 2000;101:1097-1101.
ABSTRACT | FULL TEXT  

Local Overexpression of Thrombomodulin for In Vivo Prevention of Arterial Thrombosis in a Rabbit Model
Waugh et al.
Circ. Res. 1999;84:84-92.
ABSTRACT | FULL TEXT  

Aspirin as a Therapeutic Agent in Cardiovascular Disease : A Statement for Healthcare Professionals From the American Heart Association
Hennekens et al.
Circulation 1997;96:2751-2753.
FULL TEXT  

Remarks About Postinfarction Prognosis in Light of the Experience With the Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico (GISSI) Trials
Tavazzi and Volpi
Circulation 1997;95:1341-1345.
FULL TEXT  

Prothrombotic Effects of Erythrocytes on Platelet Reactivity: Reduction by Aspirin
Santos et al.
Circulation 1997;95:63-68.
ABSTRACT | FULL TEXT  

Aspirin in the Treatment of Acute Myocardial Infarction in Elderly Medicare Beneficiaries : Patterns of Use and Outcomes
Krumholz et al.
Circulation 1995;92:2841-2847.
ABSTRACT | FULL TEXT  

Recent Advances: Clinical pharmacology and therapeutics
Breckenridge
BMJ 1995;310:377-380.
FULL TEXT